Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

4 recalls · Class II, newest first

Class II · Moderate risk

Zicam

CGMP Deviations; FDA inspection of the contract manufacturer noted out of limit results for microbiological testing

Ongoing Microbial contamination Church & Dwight Co., Inc. D-0790-2026
Class II · Moderate risk

Semaglutide

CGMP Deviations This recall has been initiated due to failing to complete process validation and bacterial endotoxin method validation before distribution

Ongoing Microbial contamination Harbin Jixianglong Biotech Co., Ltd. NDC 84385-106-01 D-0380-2026
Class II · Moderate risk

Semaglutide

CGMP Deviations This recall has been initiated due to failing to complete process validation and bacterial endotoxin method validation before distribution

Ongoing Microbial contamination Harbin Jixianglong Biotech Co., Ltd. NDC 84385-106-01 D-0379-2026

Recalls by year